Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
agilon health, inc. stock logo
AGL
agilon health
$5.33
-0.2%
$5.68
$4.41
$26.75
$2.19B0.495.80 million shs2.70 million shs
DaVita Inc. stock logo
DVA
DaVita
$132.74
-0.9%
$131.45
$71.51
$141.54
$11.64B1.04804,150 shs472,863 shs
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
$20.76
-3.4%
$19.55
$16.37
$27.72
$12.18B1437,126 shs396,250 shs
Progyny, Inc. stock logo
PGNY
Progyny
$32.60
+0.6%
$36.36
$29.44
$44.95
$3.13B1.48784,869 shs759,101 shs
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
agilon health, inc. stock logo
AGL
agilon health
+3.39%+19.33%+9.20%-17.91%-78.66%
DaVita Inc. stock logo
DVA
DaVita
+1.03%+3.13%-0.16%+28.17%+51.91%
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
+4.53%+15.58%+14.62%+7.72%-7.73%
Progyny, Inc. stock logo
PGNY
Progyny
-2.00%-2.96%-13.00%-15.29%-6.14%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
agilon health, inc. stock logo
AGL
agilon health
1.4283 of 5 stars
4.11.00.00.01.70.00.6
DaVita Inc. stock logo
DVA
DaVita
3.5207 of 5 stars
1.22.00.04.52.72.52.5
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
3.7634 of 5 stars
2.15.02.50.02.80.03.8
Progyny, Inc. stock logo
PGNY
Progyny
4.3975 of 5 stars
4.51.00.00.03.23.33.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
agilon health, inc. stock logo
AGL
agilon health
2.18
Hold$9.4677.57% Upside
DaVita Inc. stock logo
DVA
DaVita
2.33
Hold$118.50-10.73% Downside
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
2.13
Hold$24.0015.61% Upside
Progyny, Inc. stock logo
PGNY
Progyny
3.00
Buy$48.3048.16% Upside

Current Analyst Ratings

Latest FMS, DVA, AGL, and PGNY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/22/2024
agilon health, inc. stock logo
AGL
agilon health
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$6.00
4/17/2024
Progyny, Inc. stock logo
PGNY
Progyny
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$46.00
3/6/2024
agilon health, inc. stock logo
AGL
agilon health
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageUnderweight$5.00
3/6/2024
DaVita Inc. stock logo
DVA
DaVita
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageEqual Weight$133.00
2/29/2024
agilon health, inc. stock logo
AGL
agilon health
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$13.00 ➝ $9.00
2/29/2024
agilon health, inc. stock logo
AGL
agilon health
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$10.00 ➝ $7.50
2/28/2024
agilon health, inc. stock logo
AGL
agilon health
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetIn-Line ➝ In-Line$7.00 ➝ $6.00
2/28/2024
agilon health, inc. stock logo
AGL
agilon health
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$11.00 ➝ $8.00
2/28/2024
Progyny, Inc. stock logo
PGNY
Progyny
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$48.00
2/28/2024
Progyny, Inc. stock logo
PGNY
Progyny
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$47.00 ➝ $46.00
2/28/2024
Progyny, Inc. stock logo
PGNY
Progyny
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$45.00 ➝ $43.00
(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
agilon health, inc. stock logo
AGL
agilon health
$4.32B0.51N/AN/A$1.63 per share3.27
DaVita Inc. stock logo
DVA
DaVita
$12.14B0.96$16.82 per share7.89$13.63 per share9.74
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
$19.45B0.63$4.68 per share4.44$27.34 per share0.76
Progyny, Inc. stock logo
PGNY
Progyny
$1.09B2.88$0.66 per share49.26$5.77 per share5.65

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
agilon health, inc. stock logo
AGL
agilon health
-$262.60M-$0.65N/AN/AN/A-5.76%-21.74%-8.89%5/7/2024 (Confirmed)
DaVita Inc. stock logo
DVA
DaVita
$691.53M$7.4017.9413.261.185.70%64.42%4.63%5/2/2024 (Confirmed)
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
$540.07M$0.9222.5710.931.132.56%4.99%2.15%5/14/2024 (Estimated)
Progyny, Inc. stock logo
PGNY
Progyny
$62.04M$0.6252.5833.611.375.70%12.64%8.82%5/13/2024 (Estimated)

Latest FMS, DVA, AGL, and PGNY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
agilon health, inc. stock logo
AGL
agilon health
-$0.01N/A+$0.01N/AN/AN/A  
5/2/2024N/A
DaVita Inc. stock logo
DVA
DaVita
$1.96N/A-$1.96N/AN/AN/A  
2/27/2024Q4 2023
agilon health, inc. stock logo
AGL
agilon health
-$0.28-$0.41-$0.13-$0.25$1.02 billion$1.06 billion    
2/27/2024Q4 2023
Progyny, Inc. stock logo
PGNY
Progyny
$0.09$0.13+$0.04$0.13$274.08 million$269.94 million      
2/20/2024Q4 2023
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
$0.36$0.47+$0.11$0.60$5.32 billion$5.37 billion
2/13/2024Q4 23
DaVita Inc. stock logo
DVA
DaVita
$1.53$1.87+$0.34$2.12$3.01 billion$3.15 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
agilon health, inc. stock logo
AGL
agilon health
N/AN/AN/AN/AN/A
DaVita Inc. stock logo
DVA
DaVita
N/AN/AN/AN/AN/A
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
$0.432.07%-5.51%46.74%N/A
Progyny, Inc. stock logo
PGNY
Progyny
N/AN/AN/AN/AN/A

Latest FMS, DVA, AGL, and PGNY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/15/2024
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
Annual$0.43702.35%5/17/20245/20/20246/3/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
agilon health, inc. stock logo
AGL
agilon health
0.05
1.51
1.51
DaVita Inc. stock logo
DVA
DaVita
6.65
1.19
1.13
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
0.47
1.42
1.07
Progyny, Inc. stock logo
PGNY
Progyny
N/A
3.44
3.44

Ownership

Institutional Ownership

CompanyInstitutional Ownership
agilon health, inc. stock logo
AGL
agilon health
N/A
DaVita Inc. stock logo
DVA
DaVita
90.12%
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
8.25%
Progyny, Inc. stock logo
PGNY
Progyny
94.93%

Insider Ownership

CompanyInsider Ownership
agilon health, inc. stock logo
AGL
agilon health
3.30%
DaVita Inc. stock logo
DVA
DaVita
1.40%
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
N/A
Progyny, Inc. stock logo
PGNY
Progyny
12.30%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
agilon health, inc. stock logo
AGL
agilon health
1,117411.06 million397.49 millionNot Optionable
DaVita Inc. stock logo
DVA
DaVita
70,00087.70 million86.47 millionOptionable
Fresenius Medical Care AG stock logo
FMS
Fresenius Medical Care
1,358586.83 millionN/AOptionable
Progyny, Inc. stock logo
PGNY
Progyny
56396.11 million84.29 millionOptionable

FMS, DVA, AGL, and PGNY Headlines

SourceHeadline
Jennison Associates LLC Has $94.02 Million Holdings in Progyny, Inc. (NASDAQ:PGNY)Jennison Associates LLC Has $94.02 Million Holdings in Progyny, Inc. (NASDAQ:PGNY)
marketbeat.com - April 23 at 8:30 AM
Progyny, Inc. (NASDAQ:PGNY) Shares Purchased by Kornitzer Capital Management Inc. KSProgyny, Inc. (NASDAQ:PGNY) Shares Purchased by Kornitzer Capital Management Inc. KS
marketbeat.com - April 21 at 7:54 AM
Progyny, Inc. (PGNY)Progyny, Inc. (PGNY)
finance.yahoo.com - April 20 at 8:34 PM
Progyny (NASDAQ:PGNY) Rating Reiterated by Truist FinancialProgyny (NASDAQ:PGNY) Rating Reiterated by Truist Financial
americanbankingnews.com - April 19 at 1:58 AM
Truist Financial Reaffirms "Buy" Rating for Progyny (NASDAQ:PGNY)Truist Financial Reaffirms "Buy" Rating for Progyny (NASDAQ:PGNY)
marketbeat.com - April 17 at 3:51 PM
Progyny and Fertility Matters Canada Recognize Canadian Fertility Awareness Week to Advocate for Expanded Access to Family Building CareProgyny and Fertility Matters Canada Recognize Canadian Fertility Awareness Week to Advocate for Expanded Access to Family Building Care
finance.yahoo.com - April 17 at 10:24 AM
Progyny and Fertility Matters Canada Recognize Canadian Fertility Awareness Week to Advocate for Expanded Access to Family Building CareProgyny and Fertility Matters Canada Recognize Canadian Fertility Awareness Week to Advocate for Expanded Access to Family Building Care
globenewswire.com - April 17 at 9:23 AM
Progyny, Inc. (PGNY) Interactive Stock Chart - Yahoo FinanceProgyny, Inc. (PGNY) Interactive Stock Chart - Yahoo Finance
finance.yahoo.com - April 16 at 1:52 PM
Progyny, Inc. (NASDAQ:PGNY) Shares Bought by DekaBank Deutsche GirozentraleProgyny, Inc. (NASDAQ:PGNY) Shares Bought by DekaBank Deutsche Girozentrale
marketbeat.com - April 13 at 5:58 AM
Benjamin Graham Detailed Fundamental Analysis - PGNYBenjamin Graham Detailed Fundamental Analysis - PGNY
nasdaq.com - April 10 at 2:16 PM
Baillie Gifford & Co. Decreases Holdings in Progyny, Inc. (NASDAQ:PGNY)Baillie Gifford & Co. Decreases Holdings in Progyny, Inc. (NASDAQ:PGNY)
marketbeat.com - April 10 at 8:34 AM
International Assets Investment Management LLC Raises Stock Position in Progyny, Inc. (NASDAQ:PGNY)International Assets Investment Management LLC Raises Stock Position in Progyny, Inc. (NASDAQ:PGNY)
marketbeat.com - April 6 at 7:08 AM
Progyny CFO sells over $419k in company stockProgyny CFO sells over $419k in company stock
investing.com - April 5 at 4:04 AM
Progyny executive chairman sells $37,522 in stockProgyny executive chairman sells $37,522 in stock
investing.com - April 5 at 4:04 AM
Progyny, Inc. (NASDAQ:PGNY) Shares Sold by Riverbridge Partners LLCProgyny, Inc. (NASDAQ:PGNY) Shares Sold by Riverbridge Partners LLC
marketbeat.com - April 5 at 12:49 AM
Progyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to CoastProgyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to Coast
globenewswire.com - April 4 at 8:59 AM
Progyny, Inc. (NASDAQ:PGNY) Chairman Sells $37,520.00 in StockProgyny, Inc. (NASDAQ:PGNY) Chairman Sells $37,520.00 in Stock
insidertrades.com - April 4 at 6:52 AM
Progyny, Inc. (NASDAQ:PGNY) Given Average Recommendation of "Buy" by AnalystsProgyny, Inc. (NASDAQ:PGNY) Given Average Recommendation of "Buy" by Analysts
marketbeat.com - April 4 at 2:15 AM
Insider Sell: President Michael Sturmer Sells Shares of Progyny Inc (PGNY)Insider Sell: President Michael Sturmer Sells Shares of Progyny Inc (PGNY)
finance.yahoo.com - April 3 at 9:07 PM
Progyny, Inc. (NASDAQ:PGNY) Chairman David J. Schlanger Sells 1,000 SharesProgyny, Inc. (NASDAQ:PGNY) Chairman David J. Schlanger Sells 1,000 Shares
marketbeat.com - April 3 at 6:58 PM
Executive Chairman David Schlanger Sells 71,272 Shares of Progyny Inc (PGNY)Executive Chairman David Schlanger Sells 71,272 Shares of Progyny Inc (PGNY)
finance.yahoo.com - March 30 at 8:04 AM
Progyny, Inc. (NASDAQ:PGNY) Chairman David J. Schlanger Sells 71,272 SharesProgyny, Inc. (NASDAQ:PGNY) Chairman David J. Schlanger Sells 71,272 Shares
insidertrades.com - March 30 at 7:15 AM
Insider Selling: Progyny, Inc. (NASDAQ:PGNY) Chairman Sells 71,272 Shares of StockInsider Selling: Progyny, Inc. (NASDAQ:PGNY) Chairman Sells 71,272 Shares of Stock
marketbeat.com - March 29 at 9:16 PM
Vanguard Group Inc. Has $277.52 Million Stake in Progyny, Inc. (NASDAQ:PGNY)Vanguard Group Inc. Has $277.52 Million Stake in Progyny, Inc. (NASDAQ:PGNY)
marketbeat.com - March 29 at 4:18 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

agilon health logo

agilon health

NYSE:AGL
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.
DaVita logo

DaVita

NYSE:DVA
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Fresenius Medical Care logo

Fresenius Medical Care

NYSE:FMS
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Progyny logo

Progyny

NASDAQ:PGNY
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.